9999999997-13-012541.txt : 20130812 9999999997-13-012541.hdr.sgml : 20130812 20130812085642 ACCESSION NUMBER: 9999999997-13-012541 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130812 DATE AS OF CHANGE: 20130812 20130812 20130812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 131028325 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``*.*@94P`C$+`P<#%LP(#`@-C$R(#1[Z.YR/Q8"!29`Q,`B M8)Y1,7B"`Z<@4#&(XQBNKLCM6=\E6FIE[G<)PR0*]],I652E-K8TY9AK;.;J M8Z)SK^MJERB](>N;!4G566^G4Q/^8PV_9-XHWK9#*O M\OTRM?Y$UTKOCF15U87,K>G!M21,1]^TS+/=K#SD"BA)M"I^FK\Y=/-A++9< M9R==U>1Q,(H=="X;A3%OE;\M=]4^*P_D(2MG99/UWXNL;O3U4=;@\5$5W#,N MZ;ML(Q@3)'E^TMA06C\KVUG?GGEZKX_-A@<44`+J]%#0YWD>N!B,&)^Q_;4( MSMM?/&$H(&3,X!?9XT6QC4)[[/LN3D1]9A"$UN=>H;WNY%+/-]G=K[/R]AW4 MD9D`W[K$8V7/6; M?^/-[;#;9+?E(6^6LI8:I`TWW]W<412U['7\N:DS819`MK#K4EJ"VIR%O MR/"XYZXZ'_@LX^W=O&=(_"/``+;,A=<-"F5N9'-TK%9;C]I&%'[G5QRI+^,*3SSC&\X;86%#VF6EQ9$J=:O*V`/KRMC$ MEV[HK^^9BXTAV^2EK):YV.?V?>?"N_LM@T,S^1!/WL4Q!P;Q?L(X./B'2^1` MZ,SHS(/X.''@@/]Q*K]>)P2L^*\)FX'-*/,AOC,W\<]F8[LTBBY/;>HX+)+B M9O,Z^9U\WJSCI65[-")WL+5LGX8DMB@C\UC?+LTE6'_$GR9V0,/0O];I!$:G MW$B=V^7B\],Z7EOXMH<*8+ZY`S3BTH#\MO@XW]R;`RP>'Q[6V^WZ<:/5A]0- M;I2S7CE3,<^[0]>TB,P4N,-<'2?SJ!^-O+K%R*?1K=H>!\?@\/ATMWR">\N> M8>Q/\TV\WMRC>YN5\HMQZGE(2"_-C;3/M?3Z;HD2\U\A?EK.XP<\&+A0,/!' MGAEAC;RT&']<0H\7(K4T^,!\$OH4ZE.H87:H8S)?[5SN4`:^YU+N2>>/TB@+_)&+H,,>ZL7E(<7E5L9`P)CV MU[9LYF+ZR87.R`I7!T'^"5>&#GHDMR"`I(3F=BCQ-VKRR?`RD MU#ZS&74PZYS>@-\;8*$VT)69J.&I0]:XM[,YU.)+AQI\(IHV+P^05N4^ST39 MYDG1I[)6.O9UIQ6XO$DOG:'JT(%]0`>\O#-E#IDJ\A+_L+AM^U?D]& M4$+>@OB:*OG"LC&>+A/JE!DE-=X&I-(RT+Z((5Y9%5-A22U,M-I^.A;D-32!I( MCE:(#5,@MJA0YC4CI5[@$WKLDDZ?"O7>V3S"@T]5%Y$/2Z'!K<:I%@_PHZ!O8G4&E&QO234.+2/,! M638@RTT70Q*0<-)BY8,N>L0PS1737#%M>/[2)46NG^6BD=@9S)6Q M*\B'#..&RJO,3*OC4=2IW%8U4EDFI3J@Y:J6XR<@,B;,+QU,*`?BMV4A=RI[ MI7.Z-F1NK6HALDHJP%Y1[1$4H]4G^E)',T_;:1]`>#5QKWJE[CW$A\]T2Q<4 M?)\_D]VS]4R\9VNJ#-[E?^>-5(G&%E5]JNJD5>TMI#-WE-_!+0M29J6B%_"" M<&:B%3+'D86\1+[+JI6I?^IVV"V*\\5;J?:ZMRE757J3+&_2HFH$UB4%##.M MZ@R;0W&>ZJ:++3,<>76)U%"%M5QTLA@&.D*B4TP#MZ\K?1Q5,DZC$4-#P9G1 MM:^*HGJ5#4KHBH;7O"A4>#NAQQ7'AAO<3D!3!+4HA,I_Q$*:U'@`.J>.;6XJ MV)+2!$ZBSJL,FI-(\WTNLO<_*CKE+MKW(H,`CB?3>L!2'1TQ\W&4<\_S9=1U MU1U>S*-+_U%'V5K,SN'X.X>%W$%]R@,]/SP5GYHOHWEX,U^4I]\Z><'T,FU6 M!H8%%I7"(6]D,DYE:[C)SK[K1NP_APP9,GB4G%.$O&ZZI%3IJ'^[*2UOMUG# M>H:T'1(U\;KVI:KS]OR^C^@-)K[=V&-R_"%N]5D6^3_)3K0]#0^TWW3UZ>4\ M4#[4G>+7&ZO8BK06+5*';2_X;F?^7S;+>/*O``,`7G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U M+C(M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UL.FQA;F<](G@M9&5F875L="(^36EC&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O M(CX*("`@("`@("`@/'!D9CI0&UP34TZ26YS=&%N8V5)1#YU=6ED M.CAC-6)F.68R+6%F834M-#)A8BUB,C`P+34W968R8SDP,#9B93PO>&UP34TZ M26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@+K)TP/#1!YR(Y[RV"DD*)`]S9Z&83/O'.>79UY"WKW0;'\"08`QI(X85Z MWE:,1=XT7P$&`%2H0.4-"F5N9'-TF4@,3`O5'EP92]84F5F M+U=;,2`R(#%=/CYS=')E86T-"FC>8F(``B9&;FD&)@:&-B#!%PDD&'M!!!M0 MXFD)2(*!$4@P_0<2C`P``08`5J,$&PT*96YD